Post by
Bullknit101 on Oct 01, 2020 4:11pm
Organigram
InMed is ahead of Hyasynth in cannabiboid manufacturing and yet, the SP is struggling. Either Bruce Collwill has been ineffective with the NASDAQ Listing Or InMed is getting jerked around by the SEC because it's Canadian company. The US (executive power) has never been this hostile towards it's friends and allies so I wouldn't be surprised if some stupid regulations have been imposed to stimy foreign companies. Just venting - probably not true...like WTF is going on??? https://www.cantechletter.com/2020/10/organigrams-biosynthesis-bet-is-paying-off-says-raymond-james/